{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:36:27Z","timestamp":1772750187745,"version":"3.50.1"},"reference-count":35,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Nanjing, China. Funding number is phase"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2023,3,4]]},"DOI":"10.1080\/13543784.2023.2179481","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T11:11:22Z","timestamp":1675941082000},"page":"263-270","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects"],"prefix":"10.1080","volume":"32","author":[{"given":"Yanli","family":"Wang","sequence":"first","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinling","family":"Xue","sequence":"additional","affiliation":[{"name":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengjie","family":"Su","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzi","family":"Cui","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangwen","family":"Liu","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengzhi","family":"Liu","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Chen","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Ren","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Yu","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanhua","family":"Wang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Chen","sequence":"additional","affiliation":[{"name":"Ansiterui Medical Technology Consulting Co., Ltd","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Qu","sequence":"additional","affiliation":[{"name":"Ansiterui Medical Technology Consulting Co., Ltd","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaohuan","family":"Deng","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yicheng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Puheng Technology Co., Ltd","place":["Suzhou, China"]},{"name":"Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haimiao","family":"Yang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,2,18]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-3-199908030-00008"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907153410306"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4111"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24275"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767020-00010"},{"key":"e_1_3_7_8_1","volume-title":"Gleevec (imatinib mesylate) tablets prescribing information","year":"2006","unstructured":"Gleevec (imatinib mesylate) tablets prescribing information. East Hanover NJ: Novartis Pharmaceuticals; 2006."},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002315"},{"key":"e_1_3_7_10_1","unstructured":"Sprycel (Dasatinib) Tablets Approval Letter 2006 [cited 2022 July\/27]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2006\/021986s000ltr.pdf"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.0779"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.2165\/11207580-000000000-00000"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0259"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm049486a"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055229"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-018-0639-7"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1928.1928"},{"issue":"11","key":"e_1_3_7_18_1","first-page":"889","article-title":"Study on efficiency and safety of dasatinib in Chinese patients with chronic myelogenous leukemia who are resistant or intolerant to imatinib","volume":"33","author":"Huang X","year":"2012","unstructured":"Huang X, Hu J, Li J, et al. Study on efficiency and safety of dasatinib in Chinese patients with chronic myelogenous leukemia who are resistant or intolerant to imatinib. Zhonghua xue ye xue za zhi= Zhonghua Xueyexue Zazhi. 2012;33(11): 889\u2013895","journal-title":"Zhonghua xue ye xue za zhi= Zhonghua Xueyexue Zazhi"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1162\/0034653053327694"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/08956308.2008.11657535"},{"key":"e_1_3_7_21_1","unstructured":"Clinical Pharmacology Biopharmaceutics Review of Sprycel (Dasatinib) Tablets 2005 [cited 2022 July 25]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2006\/021986s000_Sprycel__ClinPharmR.pdf"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.26.15_suppl.3590"},{"key":"e_1_3_7_23_1","unstructured":"Draft Guidance on Dasatinib 2021 [cited 2022 July 26]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_021986.pdf"},{"key":"e_1_3_7_24_1","unstructured":"Dasatinib product-specific bioequivalence guidance 2021 [cited 2022 July 26]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/dasatinib-film-coated-tablets-20-50-70-80-100-140-mg-suspension-10-mg\/ml-product-specific-bioequivalence-guidance-revision-1_en.pdf"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00872-4"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-012-9406-x"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-008-9053-4"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1017\/S109285291300059X"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S85050"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24186"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.011452"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802136384"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.221"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2011.01.006"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S42796"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181f4d9c5"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.079921"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2023.2179481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:45:17Z","timestamp":1772747117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2023.2179481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,18]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,4]]}},"alternative-id":["10.1080\/13543784.2023.2179481"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2023.2179481","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-09-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}